Tag: Anvisa

• Monday, January 4th 2021 - 05:36 UTC

  Brazil health regulator approves import of 2 million doses of AstraZeneca vaccine

  

  Brazil's health regulator Anvisa said over the weekend it had approved the import of 2 million doses of the COVID-19 vaccine developed by AstraZeneca and the University of Oxford, although the jab is not yet approved for use in the country.

• Wednesday, December 16th 2020 - 08:51 UTC

  Brazil's health regulator ANVISA considers Chinese Covid-19 vaccine process non transparent

  

  Brazil’s health regulator Anvisa said China’s health authorities are not transparent in their authorization of COVID-19 vaccines for emergency use, a statement that may further inflame political tension in the country.

• Thursday, December 3rd 2020 - 09:52 UTC

  Brazil's health regulator open to approving Covid-19 vaccines for emergency use

  

  Brazil’s health regulator Anvisa said on Wednesday it was open to approving COVID-19 vaccines for emergency use and outlined the requirements for companies looking to do so.

• Thursday, November 12th 2020 - 09:42 UTC

  Bolsonaro's clash with Sao Paulo governor over the Chinese vaccine tainted with politics

  

  Brazil’s national health regulator allowed clinical trials of a Chinese-developed Covid-19 vaccine to resume on Wednesday, two days after suspending them in what critics called a decision tainted by politics.

• Wednesday, November 4th 2020 - 08:46 UTC

  Johnson & Johnson resumes clinical trials of the Covid-19 vaccine in Brazil

  

  Brazilian health regulator Anvisa has authorized the resumption of a clinical trial of Johnson & Johnson's experimental COVID-19 vaccine, according to a statement from the government agency on Tuesday.

• Wednesday, August 19th 2020 - 09:58 UTC

  Brazil approved human clinical trials for a potential Johnson & Johnson Covid-19 vaccine

  

  Brazil approved on Tuesday human clinical trials for a potential COVID-19 vaccine developed by Johnson & Johnson, the fourth candidate to trial in the Latin American country that has become key to the global race for a vaccine.

• Wednesday, December 4th 2019 - 09:47 UTC

  Brazil approves the sale of cannabis-based products for medical use

  

  Brazil's health watchdog on Tuesday approved the sale of cannabis-based products for medical use in pharmacies to people with a prescription. The regulation, which takes effect in the coming months, also allows for the manufacture of such products in a laboratory, the Brazilian Health Regulatory Agency (Anvisa) said in a statement.

• Wednesday, February 27th 2019 - 09:17 UTC

  Brazil says glyphosate is non-cancerous, but health risks remain for those exposed to the weed-killer

  

  Analysts at Brazilian health agency Anvisa have determined that the weed-killer glyphosate does not cause cancer while recommending exposure limits as international pressure to reduce use of the chemical grows. Companies such as Bayer AG and its unit Monsanto, which produces glyphosate-based weed-killers, have faced legal challenges over allegations that glyphosate causes cancer. A new study published this month also links high exposure to cancer.